Jin Yang Pharmaceutical Co. Ltd (007370) - Total Liabilities

Latest as of September 2025: ₩103.72 Billion KRW ≈ $70.29 Million USD

Based on the latest financial reports, Jin Yang Pharmaceutical Co. Ltd (007370) has total liabilities worth ₩103.72 Billion KRW (≈ $70.29 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore how efficiently does Jin Yang Pharmaceutical Co. Ltd generate cash to assess how effectively this company generates cash.

Jin Yang Pharmaceutical Co. Ltd - Total Liabilities Trend (2014–2024)

This chart illustrates how Jin Yang Pharmaceutical Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. Check asset resilience ratio of Jin Yang Pharmaceutical Co. Ltd to evaluate the company's liquid asset resilience ratio.

Jin Yang Pharmaceutical Co. Ltd Competitors by Total Liabilities

The table below lists competitors of Jin Yang Pharmaceutical Co. Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Canlan Ice Sports Corp. TO:ICE	Canada	CA$80.61 Million
Panorama Sentrawisata Tbk JK:PANR	Indonesia	Rp724.87 Billion
Verde Clean Fuels Inc. NASDAQ:VGAS	USA	$3.14 Million
Danen Technology Corp TW:3686	Taiwan	NT$9.62 Million
Globalink Investment Inc NASDAQ:GLLI	USA	$9.97 Million
Coastal Corporation Limited NSE:COASTCORP	India	Rs5.29 Billion
Cherrybro co.Ltd KQ:066360	Korea	₩192.37 Billion
Sonoro Gold Corp V:SGO	Canada	CA$8.04 Million

Liability Composition Analysis (2014–2024)

This chart breaks down Jin Yang Pharmaceutical Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 007370 stock market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.52	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.81	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.45	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Jin Yang Pharmaceutical Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Jin Yang Pharmaceutical Co. Ltd (2014–2024)

The table below shows the annual total liabilities of Jin Yang Pharmaceutical Co. Ltd from 2014 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩107.70 Billion ≈ $72.98 Million	+255.16%
2023-12-31	₩30.32 Billion ≈ $20.55 Million	-17.75%
2022-12-31	₩36.87 Billion ≈ $24.99 Million	+11.10%
2021-12-31	₩33.18 Billion ≈ $22.49 Million	+52.46%
2020-12-31	₩21.77 Billion ≈ $14.75 Million	-11.56%
2019-12-31	₩24.61 Billion ≈ $16.68 Million	-12.14%
2018-12-31	₩28.01 Billion ≈ $18.98 Million	-10.98%
2017-12-31	₩31.47 Billion ≈ $21.32 Million	+13.85%
2016-12-31	₩27.64 Billion ≈ $18.73 Million	-0.31%
2015-12-31	₩27.72 Billion ≈ $18.79 Million	+82.37%
2014-12-31	₩15.20 Billion ≈ $10.30 Million	--

About Jin Yang Pharmaceutical Co. Ltd

KQ:007370 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$41.44 Million

₩61.15 Billion KRW

Market Cap Rank

#22576 Global

#1533 in Korea

Share Price

₩4950.00

Change (1 day)

+0.20%

52-Week Range

₩4370.00 - ₩6740.00

All Time High

₩9262.22